1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Phase
        1.2.1 Global Patient Recruitment for Clinical Trials Market Size Growth Rate by Phase, 2017 VS 2021 VS 2028
        1.2.2 Phase I
        1.2.3 Phase II
        1.2.4 Phase III
        1.2.5 Phase IV
    1.3 Market by Application
        1.3.1 Global Patient Recruitment for Clinical Trials Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Respiratory Diseases
        1.3.3 Pain and Anesthesia
        1.3.4 Oncology
        1.3.5 Central Nervous System
        1.3.6 Cardiovascular
        1.3.7 Endocrine
        1.3.8 Anti-Infective
        1.3.9 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Patient Recruitment for Clinical Trials Market Perspective (2017-2028)
    2.2 Patient Recruitment for Clinical Trials Growth Trends by Region
        2.2.1 Patient Recruitment for Clinical Trials Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Patient Recruitment for Clinical Trials Historic Market Size by Region (2017-2022)
        2.2.3 Patient Recruitment for Clinical Trials Forecasted Market Size by Region (2023-2028)
    2.3 Patient Recruitment for Clinical Trials Market Dynamics
        2.3.1 Patient Recruitment for Clinical Trials Industry Trends
        2.3.2 Patient Recruitment for Clinical Trials Market Drivers
        2.3.3 Patient Recruitment for Clinical Trials Market Challenges
        2.3.4 Patient Recruitment for Clinical Trials Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Patient Recruitment for Clinical Trials Players by Revenue
        3.1.1 Global Top Patient Recruitment for Clinical Trials Players by Revenue (2017-2022)
        3.1.2 Global Patient Recruitment for Clinical Trials Revenue Market Share by Players (2017-2022)
    3.2 Global Patient Recruitment for Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Patient Recruitment for Clinical Trials Revenue
    3.4 Global Patient Recruitment for Clinical Trials Market Concentration Ratio
        3.4.1 Global Patient Recruitment for Clinical Trials Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Patient Recruitment for Clinical Trials Revenue in 2021
    3.5 Patient Recruitment for Clinical Trials Key Players Head office and Area Served
    3.6 Key Players Patient Recruitment for Clinical Trials Product Solution and Service
    3.7 Date of Enter into Patient Recruitment for Clinical Trials Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Patient Recruitment for Clinical Trials Breakdown Data by Phase
    4.1 Global Patient Recruitment for Clinical Trials Historic Market Size by Phase (2017-2022)
    4.2 Global Patient Recruitment for Clinical Trials Forecasted Market Size by Phase (2023-2028)
5 Patient Recruitment for Clinical Trials Breakdown Data by Application
    5.1 Global Patient Recruitment for Clinical Trials Historic Market Size by Application (2017-2022)
    5.2 Global Patient Recruitment for Clinical Trials Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Patient Recruitment for Clinical Trials Market Size (2017-2028)
    6.2 North America Patient Recruitment for Clinical Trials Market Size by Phase
        6.2.1 North America Patient Recruitment for Clinical Trials Market Size by Phase (2017-2022)
        6.2.2 North America Patient Recruitment for Clinical Trials Market Size by Phase (2023-2028)
        6.2.3 North America Patient Recruitment for Clinical Trials Market Share by Phase (2017-2028)
    6.3 North America Patient Recruitment for Clinical Trials Market Size by Application
        6.3.1 North America Patient Recruitment for Clinical Trials Market Size by Application (2017-2022)
        6.3.2 North America Patient Recruitment for Clinical Trials Market Size by Application (2023-2028)
        6.3.3 North America Patient Recruitment for Clinical Trials Market Share by Application (2017-2028)
    6.4 North America Patient Recruitment for Clinical Trials Market Size by Country
        6.4.1 North America Patient Recruitment for Clinical Trials Market Size by Country (2017-2022)
        6.4.2 North America Patient Recruitment for Clinical Trials Market Size by Country (2023-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe Patient Recruitment for Clinical Trials Market Size (2017-2028)
    7.2 Europe Patient Recruitment for Clinical Trials Market Size by Phase
        7.2.1 Europe Patient Recruitment for Clinical Trials Market Size by Phase (2017-2022)
        7.2.2 Europe Patient Recruitment for Clinical Trials Market Size by Phase (2023-2028)
        7.2.3 Europe Patient Recruitment for Clinical Trials Market Share by Phase (2017-2028)
    7.3 Europe Patient Recruitment for Clinical Trials Market Size by Application
        7.3.1 Europe Patient Recruitment for Clinical Trials Market Size by Application (2017-2022)
        7.3.2 Europe Patient Recruitment for Clinical Trials Market Size by Application (2023-2028)
        7.3.3 Europe Patient Recruitment for Clinical Trials Market Share by Application (2017-2028)
    7.4 Europe Patient Recruitment for Clinical Trials Market Size by Country
        7.4.1 Europe Patient Recruitment for Clinical Trials Market Size by Country (2017-2022)
        7.4.2 Europe Patient Recruitment for Clinical Trials Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Patient Recruitment for Clinical Trials Market Size (2017-2028)
    8.2 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Phase
        8.2.1 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Phase (2017-2022)
        8.2.2 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Phase (2023-2028)
        8.2.3 Asia-Pacific Patient Recruitment for Clinical Trials Market Share by Phase (2017-2028)
    8.3 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Application
        8.3.1 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Patient Recruitment for Clinical Trials Market Share by Application (2017-2028)
    8.4 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Region
        8.4.1 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia
9 Latin America
    9.1 Latin America Patient Recruitment for Clinical Trials Market Size (2017-2028)
    9.2 Latin America Patient Recruitment for Clinical Trials Market Size by Phase
        9.2.1 Latin America Patient Recruitment for Clinical Trials Market Size by Phase (2017-2022)
        9.2.2 Latin America Patient Recruitment for Clinical Trials Market Size by Phase (2023-2028)
        9.2.3 Latin America Patient Recruitment for Clinical Trials Market Share by Phase (2017-2028)
    9.3 Latin America Patient Recruitment for Clinical Trials Market Size by Application
        9.3.1 Latin America Patient Recruitment for Clinical Trials Market Size by Application (2017-2022)
        9.3.2 Latin America Patient Recruitment for Clinical Trials Market Size by Application (2023-2028)
        9.3.3 Latin America Patient Recruitment for Clinical Trials Market Share by Application (2017-2028)
    9.4 Latin America Patient Recruitment for Clinical Trials Market Size by Country
        9.4.1 Latin America Patient Recruitment for Clinical Trials Market Size by Country (2017-2022)
        9.4.2 Latin America Patient Recruitment for Clinical Trials Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Patient Recruitment for Clinical Trials Market Size (2017-2028)
    10.2 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Phase
        10.2.1 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Phase (2017-2022)
        10.2.2 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Phase (2023-2028)
        10.2.3 Middle East & Africa Patient Recruitment for Clinical Trials Market Share by Phase (2017-2028)
    10.3 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Application
        10.3.1 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Patient Recruitment for Clinical Trials Market Share by Application (2017-2028)
    10.4 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Country
        10.4.1 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Antidote
        11.1.1 Antidote Company Details
        11.1.2 Antidote Business Overview
        11.1.3 Antidote Patient Recruitment for Clinical Trials Introduction
        11.1.4 Antidote Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.1.5 Antidote Recent Developments
    11.2 Clara Health
        11.2.1 Clara Health Company Details
        11.2.2 Clara Health Business Overview
        11.2.3 Clara Health Patient Recruitment for Clinical Trials Introduction
        11.2.4 Clara Health Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.2.5 Clara Health Recent Developments
    11.3 Clariness
        11.3.1 Clariness Company Details
        11.3.2 Clariness Business Overview
        11.3.3 Clariness Patient Recruitment for Clinical Trials Introduction
        11.3.4 Clariness Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.3.5 Clariness Recent Developments
    11.4 BBK Worldwide
        11.4.1 BBK Worldwide Company Details
        11.4.2 BBK Worldwide Business Overview
        11.4.3 BBK Worldwide Patient Recruitment for Clinical Trials Introduction
        11.4.4 BBK Worldwide Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.4.5 BBK Worldwide Recent Developments
    11.5 Worldwide Clinical Trials
        11.5.1 Worldwide Clinical Trials Company Details
        11.5.2 Worldwide Clinical Trials Business Overview
        11.5.3 Worldwide Clinical Trials Patient Recruitment for Clinical Trials Introduction
        11.5.4 Worldwide Clinical Trials Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.5.5 Worldwide Clinical Trials Recent Developments
    11.6 Clinical Site Services (CCSi)
        11.6.1 Clinical Site Services (CCSi) Company Details
        11.6.2 Clinical Site Services (CCSi) Business Overview
        11.6.3 Clinical Site Services (CCSi) Patient Recruitment for Clinical Trials Introduction
        11.6.4 Clinical Site Services (CCSi) Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.6.5 Clinical Site Services (CCSi) Recent Developments
    11.7 IQVIA
        11.7.1 IQVIA Company Details
        11.7.2 IQVIA Business Overview
        11.7.3 IQVIA Patient Recruitment for Clinical Trials Introduction
        11.7.4 IQVIA Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.7.5 IQVIA Recent Developments
    11.8 PPD Inc
        11.8.1 PPD Inc Company Details
        11.8.2 PPD Inc Business Overview
        11.8.3 PPD Inc Patient Recruitment for Clinical Trials Introduction
        11.8.4 PPD Inc Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.8.5 PPD Inc Recent Developments
    11.9 Veristat
        11.9.1 Veristat Company Details
        11.9.2 Veristat Business Overview
        11.9.3 Veristat Patient Recruitment for Clinical Trials Introduction
        11.9.4 Veristat Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.9.5 Veristat Recent Developments
    11.10 Elligo Health Research
        11.10.1 Elligo Health Research Company Details
        11.10.2 Elligo Health Research Business Overview
        11.10.3 Elligo Health Research Patient Recruitment for Clinical Trials Introduction
        11.10.4 Elligo Health Research Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.10.5 Elligo Health Research Recent Developments
    11.11 AutoCruitment
        11.11.1 AutoCruitment Company Details
        11.11.2 AutoCruitment Business Overview
        11.11.3 AutoCruitment Patient Recruitment for Clinical Trials Introduction
        11.11.4 AutoCruitment Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.11.5 AutoCruitment Recent Developments
    11.12 Clinical Connection
        11.12.1 Clinical Connection Company Details
        11.12.2 Clinical Connection Business Overview
        11.12.3 Clinical Connection Patient Recruitment for Clinical Trials Introduction
        11.12.4 Clinical Connection Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.12.5 Clinical Connection Recent Developments
    11.13 Biorasi
        11.13.1 Biorasi Company Details
        11.13.2 Biorasi Business Overview
        11.13.3 Biorasi Patient Recruitment for Clinical Trials Introduction
        11.13.4 Biorasi Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.13.5 Biorasi Recent Developments
    11.14 Curavit Clinical Research
        11.14.1 Curavit Clinical Research Company Details
        11.14.2 Curavit Clinical Research Business Overview
        11.14.3 Curavit Clinical Research Patient Recruitment for Clinical Trials Introduction
        11.14.4 Curavit Clinical Research Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.14.5 Curavit Clinical Research Recent Developments
    11.15 PatientEvolution
        11.15.1 PatientEvolution Company Details
        11.15.2 PatientEvolution Business Overview
        11.15.3 PatientEvolution Patient Recruitment for Clinical Trials Introduction
        11.15.4 PatientEvolution Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.15.5 PatientEvolution Recent Developments
    11.16 Praxis
        11.16.1 Praxis Company Details
        11.16.2 Praxis Business Overview
        11.16.3 Praxis Patient Recruitment for Clinical Trials Introduction
        11.16.4 Praxis Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.16.5 Praxis Recent Developments
    11.17 MMG
        11.17.1 MMG Company Details
        11.17.2 MMG Business Overview
        11.17.3 MMG Patient Recruitment for Clinical Trials Introduction
        11.17.4 MMG Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.17.5 MMG Recent Developments
    11.18 Science37
        11.18.1 Science37 Company Details
        11.18.2 Science37 Business Overview
        11.18.3 Science37 Patient Recruitment for Clinical Trials Introduction
        11.18.4 Science37 Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.18.5 Science37 Recent Developments
    11.19 StudyKIK
        11.19.1 StudyKIK Company Details
        11.19.2 StudyKIK Business Overview
        11.19.3 StudyKIK Patient Recruitment for Clinical Trials Introduction
        11.19.4 StudyKIK Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.19.5 StudyKIK Recent Developments
    11.20 Global AES
        11.20.1 Global AES Company Details
        11.20.2 Global AES Business Overview
        11.20.3 Global AES Patient Recruitment for Clinical Trials Introduction
        11.20.4 Global AES Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.20.5 Global AES Recent Developments
    11.21 TrialSpark
        11.21.1 TrialSpark Company Details
        11.21.2 TrialSpark Business Overview
        11.21.3 TrialSpark Patient Recruitment for Clinical Trials Introduction
        11.21.4 TrialSpark Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.21.5 TrialSpark Recent Developments
    11.22 WCG ThreeWire
        11.22.1 WCG ThreeWire Company Details
        11.22.2 WCG ThreeWire Business Overview
        11.22.3 WCG ThreeWire Patient Recruitment for Clinical Trials Introduction
        11.22.4 WCG ThreeWire Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.22.5 WCG ThreeWire Recent Developments
    11.23 Trialfacts
        11.23.1 Trialfacts Company Details
        11.23.2 Trialfacts Business Overview
        11.23.3 Trialfacts Patient Recruitment for Clinical Trials Introduction
        11.23.4 Trialfacts Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.23.5 Trialfacts Recent Developments
    11.24 Shanghai Jsure
        11.24.1 Shanghai Jsure Company Details
        11.24.2 Shanghai Jsure Business Overview
        11.24.3 Shanghai Jsure Patient Recruitment for Clinical Trials Introduction
        11.24.4 Shanghai Jsure Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
        11.24.5 Shanghai Jsure Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer


